A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.

Non ancora tradotto Non ancora tradotto
Autori
Categoria Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
Loading references information
The hypothesis of the study is that at least one dose of CP 690 550 is superior to placebo (inactive drug) in inducing remission in patients with moderate to severe ulcerative colitis.
Epistemonikos ID: 0d6909f9bcd44038790cc49e274a7d1a0258fe5f
First added on: Mar 23, 2022